AstraZeneca and Dako Denmark announced that they will collaborate on developing companion diagnostics for AstraZeneca’s oncology drugs in development. Diagnostic specialist believes that personalised medicine has a future. This is the second diagnostics deal AstraZeneca has done in the last six months and has said it is seeking further strategic alliances with diagnostic companies.